Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,898 | -7,174 | -4,178 | -8,931 | -6,897 |
| Depreciation Amortization | 1,997 | 1,649 | 1,369 | 466 | 285 |
| Accounts payable and accrued liabilities | 217 | 635 | 419 | -71 | -130 |
| Other Working Capital | 4,981 | 5,239 | 5,436 | -600 | -1,376 |
| Other Operating Activity | 3,227 | 79 | -7 | 212 | 810 |
| Operating Cash Flow | $-2,477 | $429 | $3,039 | $-8,924 | $-7,308 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -214 | -23 | -3 | -550 | -512 |
| Other Investing Activity | 1,000 | 500 | 500 | -1,000 | -1,000 |
| Investing Cash Flow | $786 | $477 | $497 | $-1,550 | $-1,512 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 650 | 650 | 650 | 4,085 | 4,085 |
| Debt Repayment | -550 | -550 | -550 | N/A | N/A |
| Common Stock Issued | 21,319 | 3,578 | 3,624 | 381 | N/A |
| Other Financing Activity | -148 | -148 | -18 | -510 | -137 |
| Financing Cash Flow | $21,271 | $3,530 | $3,706 | $3,957 | $3,948 |
| Beginning Cash Position | 592 | 592 | 592 | 7,109 | 7,109 |
| End Cash Position | 20,173 | 5,028 | 7,834 | 592 | 2,238 |
| Net Cash Flow | $19,581 | $4,436 | $7,242 | $-6,517 | $-4,872 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,477 | 429 | 3,039 | -8,924 | -7,308 |
| Capital Expenditure | -214 | -23 | -3 | -550 | -512 |
| Free Cash Flow | -2,691 | 406 | 3,036 | -9,474 | -7,820 |